Open-Label Multicenter Trial of Glivec (Imatinib Mesylate, Formerly Known as STI571) in Combination With Chemotherapy (MTC) in Patients With Refractory or Relapsed Acute Myeloid Leukemia (AML).
Phase of Trial: Phase II
Latest Information Update: 27 Feb 2017
At a glance
- Drugs Imatinib (Primary) ; Cytarabine; Mitoxantrone; Topotecan
- Indications Acute myeloid leukaemia
- Focus Therapeutic Use
- 10 Jun 2015 According to ClinicalTrials.gov, the recruitment status of this study is unknown because the information has not been verified recently.
- 17 Sep 2008 New trial record.